奥地利直升机救援中医师对儿童创伤患者的镇痛:一项12年登记分析
该回顾性分析基于奥地利14个医师配备直升机基地的ÖAMTC HEMS数字数据库,纳入12年间<15岁、现场未机械通气的儿童创伤患者。在12324次初级任务中31.4%使用了镇痛药,其中2885例为受伤且未通气患儿。医师多选择阿片类单药(44.3%)或艾司氯胺酮单药(41.1%),<6岁与>10岁相比阿片类使用增加(37.2%升至63.4%)、艾司氯胺酮使用减少(66.1%降至48.3%)。尽管使用强效镇痛药,13.7%的任务未进行技术监测,<10%的任务交接时记录完整,无法充分评估镇痛效果;但据转运中所需呼吸措施判断,严重呼吸功能不全等副作用极少见。
要点
- 在12324次初级任务中31.4%使用了镇痛药,其中2885例为受伤且未通气患儿,多数(>75%)存在中重度疼痛。
- 医师最常选择阿片类单药(44.3%)或艾司氯胺酮单药(41.1%),两者联合占11.2%。
- <6岁与>10岁相比,阿片类使用从37.2%升至63.4%,艾司氯胺酮使用从66.1%降至48.3%。
- 艾司氯胺酮更多用于四肢伤(57.3%),高于头部伤(41.5%)和脊柱伤(32.3%)。
- <6岁患儿建立静脉通路比例较低(74.3% vs. 90.8%,p < 0.001),13.7%的任务未进行技术监测。
适用人群与场景
- 奥地利14个医师配备直升机基地的初级任务中,<15岁儿童创伤患者,且现场未机械通气。
- 按年龄分为0-5岁(n=443)、6-10岁(n=902)、11-14岁(n=1540)三组。
处置流程与药物剂量
- 医师镇痛的药物选择包括阿片类单药(n=1277;44.3%)、艾司氯胺酮单药(n=1187;41.1%)或两者联合(n=324;11.2%)。
- <6岁患儿静脉通路建立比例低于>10岁组(74.3% vs. 90.8%;p < 0.001)。
- 所有任务中31.4%(3874/12324)使用了镇痛药。
红旗征与不能漏的情况
- 尽管使用强效镇痛药,396次任务(13.7%)未进行技术监测。
- 转运中严重副作用如呼吸功能不全极少见,但据转运中所需呼吸措施判断。
研究设计与关键结果
- 研究类型为回顾性登记分析,数据来自ÖAMTC HEMS数字数据库,覆盖奥地利14个医师配备直升机基地,时间跨度12年。
- 在所有飞行任务中,8.2%专门用于<15岁儿童;在全部初级任务中,31.4%(3874/12324)使用了镇痛药,其中2885例为受伤且未通气患儿。
- 多数患儿(>75%)存在中重度疼痛,支持立即镇痛。
- 医师最常选择阿片类单药(n=1277;44.3%)或艾司氯胺酮单药(n=1187;41.1%),联合用药占11.2%(n=324)。
- <6岁与>10岁相比,阿片类使用从37.2%升至63.4%,艾司氯胺酮使用从66.1%降至48.3%。
- 艾司氯胺酮在四肢伤中使用比例(57.3%)高于头部伤(41.5%)和脊柱伤(32.3%)。
- <6岁患儿静脉通路建立比例低于>10岁组(74.3% vs. 90.8%;p < 0.001)。
- 396次任务(13.7%)未进行技术监测;交接时记录完整者<10%,无法充分评估镇痛效果,但严重呼吸功能不全等副作用极少见。
证据类型、等级与局限
- 证据类型:回顾性登记分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在医师配备的直升机急救中,儿童创伤患者常接受阿片类和艾司氯胺酮镇痛;就转运中严重呼吸功能不全而言,这些强效镇痛药似乎安全。
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: As pediatric patients are typically rare among helicopter emergency medical systems (HEMS), children might be at risk for oligo-analgesia due to the rescuer's lack of experience and the fear of side effects.
METHODS: In this retrospective analysis, data was obtained from the ÖAMTC HEMS digital database including 14 physician staffed helicopter bases in Austria over a 12-year timeframe. Primary missions involving pediatric trauma patients (< 15 years) not mechanically ventilated on-site were included. Analgesia was assessed and compared between the age groups 0-5, 6-10 and 11-14 years.
RESULTS: Of all flight missions, 8.2% were dedicated to children < 15 years. Analgetic drugs were administered in 31.4% of all primary missions (3874 of 12,324), wherefrom 2885 were injured and non-ventilated (0-5 yrs.: n = 443; 6-10 yrs.: n = 902; 11-14 yrs.: n = 1540). The majority of these patients (> 75%) suffered moderate to severe pain, justifying immediate analgesia. HEMS physicians typically chose a monotherapy with an opioid (n = 1277; 44.3%) or Esketamine (n = 1187; 41.1%) followed by the combination of both (n = 324; 11.2%). Opioid use increased (37.2% to 63.4%) and Esketamine use decreased (66.1% to 48.3%) in children < 6 vs. > 10 years. Esketamine was more often administered in extremity (57.3%) than in head (41.5%) or spine injuries (32.3%). An intravenous access was less often established in children < 6 years (74.3% vs. 90.8%; p < 0.001). Despite the use of potent analgesics, 396 missions (13.7%) were performed without technical monitoring. Particularly regarding patient data at handover in hospital, merely < 10% of all missions featured complete documentation. Therefore, sufficient evaluation of the efficacy of pain relief was not possible. Yet, by means of respiratory measures required during transport, severe side effects such as respiratory insufficiency, were barely noted.
CONCLUSIONS: In the physician-staffed HEMS setting, pediatric trauma patients liberally receive opioids and Esketamine for analgesia. With regard to severe respiratory insufficiency during transport, the application of these potent analgesics seems safe.
参考来源
- Rugg C, Woyke S, Ausserer J, et al. Analgesia in pediatric trauma patients in physician-staffed Austrian helicopter rescue: a 12-year registry analysis. Scand J Trauma Resusc Emerg Med. 2021. PMID: 34794486. doi:10.1186/s13049-021-00978-z
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。